Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Senti Biosciences
company
About
Senti Biosciences is a developer of a programmable biology platform for cancer therapies.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $105M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$158.22M
Senti Biosciences has raised a total of
$158.22M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2021 | Series B | $105M | 1 | — | — | Detail |
| Feb 27, 2018 | Series A | $53M | 2 | — | — | Detail |
| Dec 19, 2017 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
Senti Biosciences is funded by 4 investors.
National Science Foundation
and Gaingels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Gaingels
|
— | Series B |
Goodman Capital
|
— | Series A |
Allen & Company
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
